Development of a consumer information leaflet for a prototype over-the-counter mifepristone and misoprostol medication abortion product
Abstract
OBJECTIVES: To develop a well-understood consumer information leaflet for a prototype over-the-counter mifepristone-misoprostol medication abortion product. STUDY DESIGN: From July 2022 to February 2024, we recruited a general population of English-speaking reproductive-age females to review a leaflet during cognitive video interviews. We revised the leaflet iteratively throughout the interviews until reaching saturation in participant feedback. RESULTS: Sixty-three people aged 13 to 49 completed interviews and found the consumer information leaflet to be easy to understand, suggesting minor improvements. CONCLUSIONS: Information related to the use of medication abortion, formatted as a consumer information leaflet for an over-the-counter product, is well understood by potential users.
Fields of Study & Subjects
Reproductive Health and Contraception
Pharmacovigilance and Adverse Drug Reactions
Pharmaceutical Quality and Counterfeiting
Publication details
- Journal / source
- Contraception
- Volume
- 156
- Pages
- 111361–111361
- Publication date
- 2 January 2026
- Language
- EN